0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antithrombin Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-33F6713
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Antithrombin Market Insights and Forecast to 2028

Global Antithrombin Market Insights and Forecast to 2028

Code: QYRE-Auto-33F6713
Report
January 2022
Pages:93
QYResearch
Description
Table of Content
Tables & Figures
Market Analysis and Insights: Global Antithrombin Market

Due to the COVID-19 pandemic, the global Antithrombin market size is estimated to be worth US$ 537.5 million in 2022 and is forecast to a readjusted size of US$ 691.6 million by 2028 with a CAGR of 4.3% during the review period.

Fully considering the economic change by this health crisis, Liquid accounting for % of the Antithrombin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Diagnostics segment is altered to an % CAGR throughout this forecast period.
China Antithrombin market size is valued at US$ million in 2021, while the US and Europe Antithrombin are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Antithrombin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Antithrombin include Grifols, rEVO Biologics Inc., Takeda, Kedrion S.p.A., CSL Limited, Scripps Laboratories Inc. and Lee Biosolutions, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Antithrombin Scope and Segment
Antithrombin market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Antithrombin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Liquid
Lyophilized

Segment by Application

Diagnostics
Therapeutics
Research

BY COMPANY

Grifols
rEVO Biologics Inc.
Takeda
Kedrion S.p.A.
CSL Limited
Scripps Laboratories Inc.
Lee Biosolutions

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Antithrombin Product Introduction
1.2 Market by Type
1.2.1 Global Antithrombin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Liquid
1.2.3 Lyophilized
1.3 Market by Application
1.3.1 Global Antithrombin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Diagnostics
1.3.3 Therapeutics
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antithrombin Sales Estimates and Forecasts 2017-2028
2.2 Global Antithrombin Revenue Estimates and Forecasts 2017-2028
2.3 Global Antithrombin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Antithrombin Sales by Region
2.4.1 Global Antithrombin Sales by Region (2017-2022)
2.4.2 Global Sales Antithrombin by Region (2023-2028)
2.5 Global Antithrombin Revenue by Region
2.5.1 Global Antithrombin Revenue by Region (2017-2022)
2.5.2 Global Antithrombin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antithrombin Sales by Manufacturers
3.1.1 Global Top Antithrombin Manufacturers by Sales (2017-2022)
3.1.2 Global Antithrombin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antithrombin in 2021
3.2 Global Antithrombin Revenue by Manufacturers
3.2.1 Global Antithrombin Revenue by Manufacturers (2017-2022)
3.2.2 Global Antithrombin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Antithrombin Revenue in 2021
3.3 Global Antithrombin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antithrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antithrombin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antithrombin Sales by Type
4.1.1 Global Antithrombin Historical Sales by Type (2017-2022)
4.1.2 Global Antithrombin Forecasted Sales by Type (2023-2028)
4.1.3 Global Antithrombin Sales Market Share by Type (2017-2028)
4.2 Global Antithrombin Revenue by Type
4.2.1 Global Antithrombin Historical Revenue by Type (2017-2022)
4.2.2 Global Antithrombin Forecasted Revenue by Type (2023-2028)
4.2.3 Global Antithrombin Revenue Market Share by Type (2017-2028)
4.3 Global Antithrombin Price by Type
4.3.1 Global Antithrombin Price by Type (2017-2022)
4.3.2 Global Antithrombin Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Antithrombin Sales by Application
5.1.1 Global Antithrombin Historical Sales by Application (2017-2022)
5.1.2 Global Antithrombin Forecasted Sales by Application (2023-2028)
5.1.3 Global Antithrombin Sales Market Share by Application (2017-2028)
5.2 Global Antithrombin Revenue by Application
5.2.1 Global Antithrombin Historical Revenue by Application (2017-2022)
5.2.2 Global Antithrombin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Antithrombin Revenue Market Share by Application (2017-2028)
5.3 Global Antithrombin Price by Application
5.3.1 Global Antithrombin Price by Application (2017-2022)
5.3.2 Global Antithrombin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antithrombin Market Size by Type
6.1.1 North America Antithrombin Sales by Type (2017-2028)
6.1.2 North America Antithrombin Revenue by Type (2017-2028)
6.2 North America Antithrombin Market Size by Application
6.2.1 North America Antithrombin Sales by Application (2017-2028)
6.2.2 North America Antithrombin Revenue by Application (2017-2028)
6.3 North America Antithrombin Market Size by Country
6.3.1 North America Antithrombin Sales by Country (2017-2028)
6.3.2 North America Antithrombin Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Antithrombin Market Size by Type
7.1.1 Europe Antithrombin Sales by Type (2017-2028)
7.1.2 Europe Antithrombin Revenue by Type (2017-2028)
7.2 Europe Antithrombin Market Size by Application
7.2.1 Europe Antithrombin Sales by Application (2017-2028)
7.2.2 Europe Antithrombin Revenue by Application (2017-2028)
7.3 Europe Antithrombin Market Size by Country
7.3.1 Europe Antithrombin Sales by Country (2017-2028)
7.3.2 Europe Antithrombin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antithrombin Market Size by Type
8.1.1 Asia Pacific Antithrombin Sales by Type (2017-2028)
8.1.2 Asia Pacific Antithrombin Revenue by Type (2017-2028)
8.2 Asia Pacific Antithrombin Market Size by Application
8.2.1 Asia Pacific Antithrombin Sales by Application (2017-2028)
8.2.2 Asia Pacific Antithrombin Revenue by Application (2017-2028)
8.3 Asia Pacific Antithrombin Market Size by Region
8.3.1 Asia Pacific Antithrombin Sales by Region (2017-2028)
8.3.2 Asia Pacific Antithrombin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Antithrombin Market Size by Type
9.1.1 Latin America Antithrombin Sales by Type (2017-2028)
9.1.2 Latin America Antithrombin Revenue by Type (2017-2028)
9.2 Latin America Antithrombin Market Size by Application
9.2.1 Latin America Antithrombin Sales by Application (2017-2028)
9.2.2 Latin America Antithrombin Revenue by Application (2017-2028)
9.3 Latin America Antithrombin Market Size by Country
9.3.1 Latin America Antithrombin Sales by Country (2017-2028)
9.3.2 Latin America Antithrombin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antithrombin Market Size by Type
10.1.1 Middle East and Africa Antithrombin Sales by Type (2017-2028)
10.1.2 Middle East and Africa Antithrombin Revenue by Type (2017-2028)
10.2 Middle East and Africa Antithrombin Market Size by Application
10.2.1 Middle East and Africa Antithrombin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Antithrombin Revenue by Application (2017-2028)
10.3 Middle East and Africa Antithrombin Market Size by Country
10.3.1 Middle East and Africa Antithrombin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Antithrombin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Grifols
11.1.1 Grifols Corporation Information
11.1.2 Grifols Overview
11.1.3 Grifols Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Grifols Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Grifols Recent Developments
11.2 rEVO Biologics Inc.
11.2.1 rEVO Biologics Inc. Corporation Information
11.2.2 rEVO Biologics Inc. Overview
11.2.3 rEVO Biologics Inc. Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 rEVO Biologics Inc. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 rEVO Biologics Inc. Recent Developments
11.3 Takeda
11.3.1 Takeda Corporation Information
11.3.2 Takeda Overview
11.3.3 Takeda Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Takeda Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Takeda Recent Developments
11.4 Kedrion S.p.A.
11.4.1 Kedrion S.p.A. Corporation Information
11.4.2 Kedrion S.p.A. Overview
11.4.3 Kedrion S.p.A. Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Kedrion S.p.A. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Kedrion S.p.A. Recent Developments
11.5 CSL Limited
11.5.1 CSL Limited Corporation Information
11.5.2 CSL Limited Overview
11.5.3 CSL Limited Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 CSL Limited Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 CSL Limited Recent Developments
11.6 Scripps Laboratories Inc.
11.6.1 Scripps Laboratories Inc. Corporation Information
11.6.2 Scripps Laboratories Inc. Overview
11.6.3 Scripps Laboratories Inc. Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Scripps Laboratories Inc. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Scripps Laboratories Inc. Recent Developments
11.7 Lee Biosolutions
11.7.1 Lee Biosolutions Corporation Information
11.7.2 Lee Biosolutions Overview
11.7.3 Lee Biosolutions Antithrombin Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Lee Biosolutions Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Lee Biosolutions Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antithrombin Industry Chain Analysis
12.2 Antithrombin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antithrombin Production Mode & Process
12.4 Antithrombin Sales and Marketing
12.4.1 Antithrombin Sales Channels
12.4.2 Antithrombin Distributors
12.5 Antithrombin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antithrombin Industry Trends
13.2 Antithrombin Market Drivers
13.3 Antithrombin Market Challenges
13.4 Antithrombin Market Restraints
14 Key Findings in The Global Antithrombin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Antithrombin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Liquid
    Table 3. Major Manufacturers of Lyophilized
    Table 4. Global Antithrombin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Antithrombin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Antithrombin Sales by Region (2017-2022) & (Units)
    Table 7. Global Antithrombin Sales Market Share by Region (2017-2022)
    Table 8. Global Antithrombin Sales by Region (2023-2028) & (Units)
    Table 9. Global Antithrombin Sales Market Share by Region (2023-2028)
    Table 10. Global Antithrombin Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Antithrombin Revenue Market Share by Region (2017-2022)
    Table 12. Global Antithrombin Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Antithrombin Revenue Market Share by Region (2023-2028)
    Table 14. Global Antithrombin Sales by Manufacturers (2017-2022) & (Units)
    Table 15. Global Antithrombin Sales Share by Manufacturers (2017-2022)
    Table 16. Global Antithrombin Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Antithrombin Revenue Share by Manufacturers (2017-2022)
    Table 18. Antithrombin Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 19. Global Antithrombin Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Antithrombin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antithrombin as of 2021)
    Table 21. Antithrombin Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Antithrombin Product Offered
    Table 23. Date of Manufacturers Enter into Antithrombin Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Antithrombin Sales by Type (2017-2022) & (Units)
    Table 26. Global Antithrombin Sales by Type (2023-2028) & (Units)
    Table 27. Global Antithrombin Sales Share by Type (2017-2022)
    Table 28. Global Antithrombin Sales Share by Type (2023-2028)
    Table 29. Global Antithrombin Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Antithrombin Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Antithrombin Revenue Share by Type (2017-2022)
    Table 32. Global Antithrombin Revenue Share by Type (2023-2028)
    Table 33. Antithrombin Price by Type (2017-2022) & (US$/Unit)
    Table 34. Global Antithrombin Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 35. Global Antithrombin Sales by Application (2017-2022) & (Units)
    Table 36. Global Antithrombin Sales by Application (2023-2028) & (Units)
    Table 37. Global Antithrombin Sales Share by Application (2017-2022)
    Table 38. Global Antithrombin Sales Share by Application (2023-2028)
    Table 39. Global Antithrombin Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Antithrombin Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Antithrombin Revenue Share by Application (2017-2022)
    Table 42. Global Antithrombin Revenue Share by Application (2023-2028)
    Table 43. Antithrombin Price by Application (2017-2022) & (US$/Unit)
    Table 44. Global Antithrombin Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 45. North America Antithrombin Sales by Type (2017-2022) & (Units)
    Table 46. North America Antithrombin Sales by Type (2023-2028) & (Units)
    Table 47. North America Antithrombin Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Antithrombin Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Antithrombin Sales by Application (2017-2022) & (Units)
    Table 50. North America Antithrombin Sales by Application (2023-2028) & (Units)
    Table 51. North America Antithrombin Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Antithrombin Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Antithrombin Sales by Country (2017-2022) & (Units)
    Table 54. North America Antithrombin Sales by Country (2023-2028) & (Units)
    Table 55. North America Antithrombin Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Antithrombin Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Antithrombin Sales by Type (2017-2022) & (Units)
    Table 58. Europe Antithrombin Sales by Type (2023-2028) & (Units)
    Table 59. Europe Antithrombin Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Antithrombin Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Antithrombin Sales by Application (2017-2022) & (Units)
    Table 62. Europe Antithrombin Sales by Application (2023-2028) & (Units)
    Table 63. Europe Antithrombin Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Antithrombin Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Antithrombin Sales by Country (2017-2022) & (Units)
    Table 66. Europe Antithrombin Sales by Country (2023-2028) & (Units)
    Table 67. Europe Antithrombin Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Antithrombin Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Antithrombin Sales by Type (2017-2022) & (Units)
    Table 70. Asia Pacific Antithrombin Sales by Type (2023-2028) & (Units)
    Table 71. Asia Pacific Antithrombin Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Antithrombin Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Antithrombin Sales by Application (2017-2022) & (Units)
    Table 74. Asia Pacific Antithrombin Sales by Application (2023-2028) & (Units)
    Table 75. Asia Pacific Antithrombin Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Antithrombin Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Antithrombin Sales by Region (2017-2022) & (Units)
    Table 78. Asia Pacific Antithrombin Sales by Region (2023-2028) & (Units)
    Table 79. Asia Pacific Antithrombin Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Antithrombin Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Antithrombin Sales by Type (2017-2022) & (Units)
    Table 82. Latin America Antithrombin Sales by Type (2023-2028) & (Units)
    Table 83. Latin America Antithrombin Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Antithrombin Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Antithrombin Sales by Application (2017-2022) & (Units)
    Table 86. Latin America Antithrombin Sales by Application (2023-2028) & (Units)
    Table 87. Latin America Antithrombin Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Antithrombin Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Antithrombin Sales by Country (2017-2022) & (Units)
    Table 90. Latin America Antithrombin Sales by Country (2023-2028) & (Units)
    Table 91. Latin America Antithrombin Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Antithrombin Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Antithrombin Sales by Type (2017-2022) & (Units)
    Table 94. Middle East and Africa Antithrombin Sales by Type (2023-2028) & (Units)
    Table 95. Middle East and Africa Antithrombin Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Antithrombin Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Antithrombin Sales by Application (2017-2022) & (Units)
    Table 98. Middle East and Africa Antithrombin Sales by Application (2023-2028) & (Units)
    Table 99. Middle East and Africa Antithrombin Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Antithrombin Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Antithrombin Sales by Country (2017-2022) & (Units)
    Table 102. Middle East and Africa Antithrombin Sales by Country (2023-2028) & (Units)
    Table 103. Middle East and Africa Antithrombin Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Antithrombin Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Grifols Corporation Information
    Table 106. Grifols Description and Major Businesses
    Table 107. Grifols Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 108. Grifols Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Grifols Recent Developments
    Table 110. rEVO Biologics Inc. Corporation Information
    Table 111. rEVO Biologics Inc. Description and Major Businesses
    Table 112. rEVO Biologics Inc. Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 113. rEVO Biologics Inc. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. rEVO Biologics Inc. Recent Developments
    Table 115. Takeda Corporation Information
    Table 116. Takeda Description and Major Businesses
    Table 117. Takeda Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 118. Takeda Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Takeda Recent Developments
    Table 120. Kedrion S.p.A. Corporation Information
    Table 121. Kedrion S.p.A. Description and Major Businesses
    Table 122. Kedrion S.p.A. Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 123. Kedrion S.p.A. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Kedrion S.p.A. Recent Developments
    Table 125. CSL Limited Corporation Information
    Table 126. CSL Limited Description and Major Businesses
    Table 127. CSL Limited Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 128. CSL Limited Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. CSL Limited Recent Developments
    Table 130. Scripps Laboratories Inc. Corporation Information
    Table 131. Scripps Laboratories Inc. Description and Major Businesses
    Table 132. Scripps Laboratories Inc. Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 133. Scripps Laboratories Inc. Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Scripps Laboratories Inc. Recent Developments
    Table 135. Lee Biosolutions Corporation Information
    Table 136. Lee Biosolutions Description and Major Businesses
    Table 137. Lee Biosolutions Antithrombin Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 138. Lee Biosolutions Antithrombin Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Lee Biosolutions Recent Developments
    Table 140. Key Raw Materials Lists
    Table 141. Raw Materials Key Suppliers Lists
    Table 142. Antithrombin Distributors List
    Table 143. Antithrombin Customers List
    Table 144. Antithrombin Market Trends
    Table 145. Antithrombin Market Drivers
    Table 146. Antithrombin Market Challenges
    Table 147. Antithrombin Market Restraints
    Table 148. Research Programs/Design for This Report
    Table 149. Key Data Information from Secondary Sources
    Table 150. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antithrombin Product Picture
    Figure 3. Global Antithrombin Market Share by Type in 2021 & 2028
    Figure 3. Liquid Product Picture
    Figure 4. Lyophilized Product Picture
    Figure 5. Global Antithrombin Market Share by Application in 2021 & 2028
    Figure 6. Diagnostics
    Figure 7. Therapeutics
    Figure 8. Research
    Figure 9. Antithrombin Report Years Considered
    Figure 10. Global Antithrombin Sales 2017-2028 (Units)
    Figure 11. Global Antithrombin Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Antithrombin Revenue 2017-2028 (US$ Million)
    Figure 13. Global Antithrombin Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Antithrombin Sales Market Share by Region (2017-2022)
    Figure 15. Global Antithrombin Sales Market Share by Region (2023-2028)
    Figure 16. North America Antithrombin Sales YoY (2017-2028) & (Units)
    Figure 17. North America Antithrombin Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Antithrombin Sales YoY (2017-2028) & (Units)
    Figure 19. Europe Antithrombin Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Antithrombin Sales YoY (2017-2028) & (Units)
    Figure 21. Asia-Pacific Antithrombin Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Antithrombin Sales YoY (2017-2028) & (Units)
    Figure 23. Latin America Antithrombin Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Antithrombin Sales YoY (2017-2028) & (Units)
    Figure 25. Middle East & Africa Antithrombin Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Antithrombin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Antithrombin in the World: Market Share by Antithrombin Revenue in 2021
    Figure 28. Global Antithrombin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Antithrombin Sales Market Share by Type (2017-2028)
    Figure 30. Global Antithrombin Revenue Market Share by Type (2017-2028)
    Figure 31. Global Antithrombin Sales Market Share by Application (2017-2028)
    Figure 32. Global Antithrombin Revenue Market Share by Application (2017-2028)
    Figure 33. North America Antithrombin Sales Market Share by Type (2017-2028)
    Figure 34. North America Antithrombin Revenue Market Share by Type (2017-2028)
    Figure 35. North America Antithrombin Sales Market Share by Application (2017-2028)
    Figure 36. North America Antithrombin Revenue Market Share by Application (2017-2028)
    Figure 37. North America Antithrombin Sales Share by Country (2017-2028)
    Figure 38. North America Antithrombin Revenue Share by Country (2017-2028)
    Figure 39. U.S. Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Antithrombin Sales Market Share by Type (2017-2028)
    Figure 42. Europe Antithrombin Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Antithrombin Sales Market Share by Application (2017-2028)
    Figure 44. Europe Antithrombin Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Antithrombin Sales Share by Country (2017-2028)
    Figure 46. Europe Antithrombin Revenue Share by Country (2017-2028)
    Figure 47. Germany Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 48. France Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Antithrombin Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Antithrombin Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Antithrombin Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Antithrombin Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Antithrombin Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Antithrombin Revenue Share by Region (2017-2028)
    Figure 58. China Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 61. India Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 63. Taiwan Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 67. Philippines Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 68. Latin America Antithrombin Sales Market Share by Type (2017-2028)
    Figure 69. Latin America Antithrombin Revenue Market Share by Type (2017-2028)
    Figure 70. Latin America Antithrombin Sales Market Share by Application (2017-2028)
    Figure 71. Latin America Antithrombin Revenue Market Share by Application (2017-2028)
    Figure 72. Latin America Antithrombin Sales Share by Country (2017-2028)
    Figure 73. Latin America Antithrombin Revenue Share by Country (2017-2028)
    Figure 74. Mexico Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 75. Brazil Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 76. Argentina Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 77. Middle East and Africa Antithrombin Sales Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Antithrombin Revenue Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Antithrombin Sales Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Antithrombin Revenue Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Antithrombin Sales Share by Country (2017-2028)
    Figure 82. Middle East and Africa Antithrombin Revenue Share by Country (2017-2028)
    Figure 83. Turkey Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 84. Saudi Arabia Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 85. UAE Antithrombin Revenue (2017-2028) & (US$ Million)
    Figure 86. Antithrombin Value Chain
    Figure 87. Antithrombin Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Bioinformatics Barcelona
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Anti-allergic Drugs Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-16R9189
Fri Jan 27 00:00:00 UTC 2023

Add to Cart

Global Cone-rod Dystrophy Treatment Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-14N9232
Fri Jan 27 00:00:00 UTC 2023

Add to Cart

Global Pharmaceutical Aseptic Filling Services Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-27N8979
Fri Jan 27 00:00:00 UTC 2023

Add to Cart

Global Human Organs-on-Chips Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-39D8996
Fri Jan 27 00:00:00 UTC 2023

Add to Cart